Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib/IIa Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies

NCT07064018 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.

NCT NCT07064018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07064018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib/IIa Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
Lead sponsor
University of California, Irvine
Phase
Phase 1/2
Overall status
Recruiting
Start date
April 30, 2025
Completion date
December 31, 2031
Enrollment
67 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, kras mutation-related tumors, non-small cell lung cancer, ovarian cancer, soft-tissue sarcoma, triple negative breast cancer